J.Jpn. Surg. Soc.. 87(9): 1201-1204, 1986
Report on the annual meeting
EVALUATION OF SURGICAL TREATMENT FOR STAGE-IV GASTRIC CANCER
|
The 2nd Department of Surgery, Jikei University School of Medicine, Tokyo, Japan Nobuhiro Takahashi, Katsuya Hirai, Akio Ohtsuka, Masahito Takahashi, Akira Kimura, Shinobu Yoshida, Fusahiro Nagao |
1) There was no significant difference in survival rate whether patients had combined resection of other organ and, or extended lymphadenectomy or not.
2) The patients who died within 1 year after surgery had more extended surgical treatment than the survivor over 3 years after surgery, and in the latter, extent of lymph node metastasis and the number of patients with cancerous invasion into other organs was less than the former.
3) In patients with peritoneal metastasis, there was no significant difference in survival rate whether they had extended surgical treatment or not.
4) There was no significant difference between P1 and P2, and between P3 and unresected patients. P1 and P2 had prolonged survival rate than P3 significantly.
The above results suggest that extended surgical treatment for Stage IV gastric cancer will be effective particularly in patients with less extent of lymph node metastasis and cancerous invasion. Resection in patients with advanced peritoneal metastasis is not useful for prolongation of survival rate.
To read the PDF file you will need Adobe Reader installed on your computer.